This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rose, S. R. Articles by Heideman, R. L. Search for Related Content PubMed PubMed Citation Articles by Rose, S. R. Articles by Heideman, R. L.

Diagnosis of Hidden Central Hypothyroidism in Survivors of Childhood Cancer¹

University of Tennessee, St. Jude Children’s Research Hospital, and Methodist LeBonheur Children’s Medical Center, Memphis, Tennessee 38103

Address all correspondence and requests for reprints to: Susan R. Rose, M.D., 50 North Dunlap, Fourth Floor, Memphis, Tennessee 38103. E-mail: srose{at}utmem1.utmem.edu

To determine how often central hypothyroidism remains undetected by routine out-patient tests of thyroid hormone, we studied 208 pediatric cancer survivors referred for evaluation because of signs of subtle hypothyroidism or hypopituitarism. Of the 208 (68 females and 140 males), 110 had brain tumors, 14 had other head/neck tumors, 11 had solid tumors remote from head and neck, and 73 had leukemia. Patients were evaluated 1–16 yr (mean, 6.1 ± 4.1 yr) after tumor diagnosis. The nocturnal TSH surge and response to TRH were measured. Of 160 patients with free T₄ in lowest third of normal, 34% had central hypothyroidism (blunted TSH surge or low/delayed TSH peak or delayed TSH decline after TRH); 9% had central hypothyroidism with mild TSH elevation (mixed hypothyroidism). Another 16% had mild primary hypothyroidism (TSH, 5–15 mU/L). Of 48 with free T₄ in the upper two thirds of normal, 14% had central hypothyroidism; 17% had mild primary hypothyroidism. Incidence of central, mixed, and mild primary hypothyroidism 10 yr after tumor diagnosis was significantly related to total cranial radiation dose (P < 0.0001). Of 62 patients with central hypothyroidism, 34% had not developed GH deficiency. TSH surge identified 71%, and response to TRH identified 60% of those with central hypothyroidism. More than half of the slowly growing patients who have received cranial or craniospinal radiation for childhood cancer develop subtle hypothyroidism. In our study group, 92% of patients with central hypothyroidism and 27% with mixed hypothyroidism would have remained undiagnosed using baseline thyroid function tests alone. Both TSH surge and response to TRH must be evaluated to identify all of these patients.

This article has been cited by other articles:

				K. H. Darzy and S. M. Shalet Circadian and Stimulated Thyrotropin Secretion in Cranially Irradiated Adult Cancer Survivors J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6490 - 6497. [Abstract] [Full Text] [PDF]

				S. L. Spunt, T. A. Sweeney, M. M. Hudson, C. A. Billups, M. J. Krasin, and A. L. Hester Late Effects of Pelvic Rhabdomyosarcoma and Its Treatment in Female Survivors J. Clin. Oncol., October 1, 2005; 23(28): 7143 - 7151. [Abstract] [Full Text] [PDF]

				H K Gleeson and S M Shalet The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours Endocr. Relat. Cancer, December 1, 2004; 11(4): 589 - 602. [Abstract] [Full Text] [PDF]

				A. Mehta, P. C. Hindmarsh, R. G. Stanhope, C. E. Brain, M. A. Preece, and M. T. Dattani Is the Thyrotropin-Releasing Hormone Test Necessary in the Diagnosis of Central Hypothyroidism in Children J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5696 - 5703. [Abstract] [Full Text] [PDF]

				H. M. van Santen, T. Vulsma, M. G. Dijkgraaf, R. M. E. Blumer, R. Heinen, M. W. M. Jaspers, M. M. Geenen, M. O. Offringa, J. J. M. De Vijlder, and C. van den Bos No Damaging Effect of Chemotherapy in Addition to Radiotherapy on the Thyroid Axis in Young Adult Survivors of Childhood Cancer J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3657 - 3663. [Abstract] [Full Text] [PDF]

				R. H. Lustig, S. R. Post, K. Srivannaboon, S. R. Rose, R. K. Danish, G. A. Burghen, X. Xiong, S. Wu, and T. E. Merchant Risk Factors for the Development of Obesity in Children Surviving Brain Tumors J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 611 - 616. [Abstract] [Full Text] [PDF]

				N. Yamakita, T. Komaki, T. Takao, T. Murai, K. Hashimoto, and K. Yasuda Usefulness of Thyrotropin (TSH)-Releasing Hormone Test and Nocturnal Surge of TSH for Diagnosis of Isolated Deficit of TSH Secretion J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1054 - 1060. [Abstract] [Full Text]